-
Good Shroom Reports Q3, Revenue Dips 10.3% YoY, Net Profit Still Positive
Friday, June 28, 2024 - 9:29am | 419Montreal-based company, The Good Shroom (TSTX:MUSH), announced its financial results for the quarter ended on April 30, 2024. The report includes results for the subsidiary Teonan Biomedical Inc. “The consistent profitability this quarter, despite a challenging market, highlights our focused...
-
Canadian Biotech Duo Hits Psilocybin Extraction Milestone For API Development At Scale
Wednesday, May 29, 2024 - 4:27pm | 628Red Light Holland Corp. (OTCQB:TRUFF) (CSE:TRIP) (FSE: 4YX) announced the successful completion of the first phase of psilocybin extraction in collaboration with PharmAla Biotech Holdings Inc. (OTCQB:MDXXF) (CSE:MDMA). On Tuesday, the company announced the achievement of a rough powdered extract of...
-
Canadian Psychedelics Company And Nonprofit Team Up To Accelerate Access And Product Launch
Thursday, May 18, 2023 - 3:12pm | 360Health-Canada licensed psychedelics biotech Lucy Scientific Discovery (NASDAQ: LSDI) and not-for-profit psilocybin advocate organization TheraPsil have partnered toward advancing medical psilocybin access and research. Since 2019, TheraPsil has worked on lawful and compassionate access to...
-
Psyched: Australia Legalizes Psychedelics Therapy, BC's Decrim, State Bills, Millions For Trials & Clinics
Monday, February 6, 2023 - 3:54pm | 1719Australian Health Authority To Allow Psilocybin And MDMA-Assisted Therapy For Depression, PTSD Beginning on July 1, 2023, medicines containing psilocybin and MDMA can be prescribed by specifically authorized psychiatrists to treat certain mental health conditions, such as ...